NXGN Nextgen Healthcare Inc

Price (delayed)

$17.08

Market cap

$1.13B

P/E Ratio

50.24

Dividend/share

N/A

EPS

$0.34

Enterprise value

$1.15B

NextGen Healthcare, Inc. is a leading provider of ambulatory-focused technology solutions. It is empowering the transformation of ambulatory care-partnering with medical, behavioral and dental providers in their journey to value-based ...

Highlights
The quick ratio has soared by 192% YoY and by 132% from the previous quarter
The price to earnings (P/E) is 84% less than the 5-year quarterly average of 308.4
The gross margin has contracted by 5% YoY
NXGN's equity is down by 5% since the previous quarter

Key stats

What are the main financial stats of NXGN
Market
Shares outstanding
66.02M
Market cap
$1.13B
Enterprise value
$1.15B
Valuations
Price to earnings (P/E)
50.24
Price to book (P/B)
2.76
Price to sales (P/S)
1.82
EV/EBIT
33.19
EV/EBITDA
15.37
EV/Sales
1.84
Earnings
Revenue
$625.88M
EBIT
$34.77M
EBITDA
$75.1M
Free cash flow
$15.71M
Per share
EPS
$0.34
Free cash flow per share
$0.24
Book value per share
$6.18
Revenue per share
$9.4
TBVPS
$6.99
Balance sheet
Total assets
$871.02M
Total liabilities
$453.26M
Debt
$275.89M
Equity
$417.76M
Working capital
$235.44M
Liquidity
Debt to equity
0.66
Current ratio
2.53
Quick ratio
2.13
Net debt/EBITDA
0.35
Margins
EBITDA margin
12%
Gross margin
48.3%
Net margin
3.7%
Operating margin
3.7%
Efficiency
Return on assets
3.4%
Return on equity
5.4%
Return on invested capital
25.7%
Return on capital employed
4.9%
Return on sales
5.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NXGN stock price

How has the Nextgen Healthcare stock price performed over time
Intraday
-0.64%
1 week
-0.64%
1 month
-9.92%
1 year
-15.36%
YTD
-9.05%
QTD
-9.05%

Financial performance

How have Nextgen Healthcare's revenue and profit performed over time
Revenue
$625.88M
Gross profit
$302.14M
Operating income
$22.86M
Net income
$22.93M
Gross margin
48.3%
Net margin
3.7%
NXGN's net income is up by 13% QoQ
The net margin has grown by 12% from the previous quarter
NXGN's operating income is up by 7% since the previous quarter
The operating margin has increased by 6% QoQ

Growth

What is Nextgen Healthcare's growth rate over time

Valuation

What is Nextgen Healthcare stock price valuation
P/E
50.24
P/B
2.76
P/S
1.82
EV/EBIT
33.19
EV/EBITDA
15.37
EV/Sales
1.84
The price to earnings (P/E) is 84% less than the 5-year quarterly average of 308.4
Nextgen Healthcare's EPS has increased by 13% QoQ
The P/B is 4.8% below the last 4 quarters average of 2.9 but 2.2% above the 5-year quarterly average of 2.7
NXGN's equity is down by 5% since the previous quarter
The stock's price to sales (P/S) is 13% less than its last 4 quarters average of 2.1 and 9% less than its 5-year quarterly average of 2.0
The revenue has increased by 6% YoY

Efficiency

How efficient is Nextgen Healthcare business performance
The return on invested capital has declined by 46% since the previous quarter
Nextgen Healthcare's ROE has increased by 13% from the previous quarter
Nextgen Healthcare's return on sales has increased by 8% QoQ
NXGN's ROA is up by 3% from the previous quarter

Dividends

What is NXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NXGN.

Financial health

How did Nextgen Healthcare financials performed over time
The total assets is 92% more than the total liabilities
The quick ratio has soared by 192% YoY and by 132% from the previous quarter
The total liabilities has soared by 145% QoQ and by 133% YoY
The debt is 34% less than the equity
NXGN's equity is down by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.